Cancers found on the lip are usually treated with surgery. The doctor performing the surgery will try to remove all the ...

The U.S. Food and Drug Administration (FDA) has granted fast track designation to DPTX3186, a first in class oral condensate ...

Roche's giredestrant has experienced a notable turnaround after initial challenges in phase 2 trials. The company previously reported a phase 3 win for the drug in September, which was further ...

The program, called YesRx, takes in donations and dispenses oral cancer and supportive medications to those in need, giving ...

Yorkshire-based children’s cancer charity Candlelighters has provided an update on the pioneering work of the Candlelighters ...

Giredestrant significantly improves IDFS in ER-positive, HER2-negative early-stage breast cancer, surpassing standard ...

India is facing a steady rise in cancer cases, particularly oral and breast cancers, driven by lifestyle changes, tobacco use, delayed diagnosis, and environmental factors, eminent haematologist and ...

A University of Sheffield researcher has uncovered new evidence that could help improve treatment options for patients with ...

The company recently announced the acquisition of a biotech with an innovative cancer treatment. Johnson & Johnson had strong ...

A JAB dished out for free on the NHS “dramatically reduces” the risk of pregnancy complications as well as cancer, a new ...

Targeted therapies, guided by molecular testing, offer significant benefits, including fewer side effects and personalization ...

J&J's $3.05B move for Halda adds targeted oral cancer therapies and expands its prostate cancer pipeline amid rising pharma M&A.